The Pennant Group (NASDAQ:PNTG) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of The Pennant Group (NASDAQ:PNTG) from a hold rating to a buy rating in a report issued on Monday.

PNTG has been the subject of several other reports. Zacks Research upgraded The Pennant Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 20th. Wells Fargo & Company raised The Pennant Group from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $29.00 to $31.00 in a report on Tuesday, November 18th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of The Pennant Group in a research note on Monday, November 17th. Royal Bank Of Canada lifted their target price on The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. Finally, Stephens reissued an “overweight” rating and set a $40.00 target price on shares of The Pennant Group in a research note on Thursday, October 9th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, The Pennant Group currently has an average rating of “Moderate Buy” and an average price target of $33.60.

The Pennant Group Trading Up 0.1%

Shares of The Pennant Group stock opened at $28.09 on Monday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The Pennant Group has a 12-month low of $21.18 and a 12-month high of $32.00. The company has a market capitalization of $971.63 million, a price-to-earnings ratio of 37.45, a PEG ratio of 2.27 and a beta of 1.39. The firm’s 50-day moving average price is $25.12 and its two-hundred day moving average price is $25.78.

The Pennant Group (NASDAQ:PNTG) last issued its earnings results on Wednesday, November 5th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.29 by $0.01. The company had revenue of $229.04 million during the quarter, compared to analysts’ expectations of $221.96 million. The Pennant Group had a net margin of 3.15% and a return on equity of 9.37%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. On average, analysts forecast that The Pennant Group will post 0.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On The Pennant Group

A number of institutional investors have recently added to or reduced their stakes in the business. Quarry LP bought a new position in shares of The Pennant Group during the third quarter valued at $37,000. State of Alaska Department of Revenue bought a new position in The Pennant Group during the 3rd quarter worth $54,000. CIBC Private Wealth Group LLC lifted its holdings in The Pennant Group by 651.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 3,398 shares of the company’s stock worth $86,000 after buying an additional 2,946 shares during the period. Tower Research Capital LLC TRC lifted its holdings in The Pennant Group by 161.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,987 shares of the company’s stock worth $119,000 after buying an additional 2,463 shares during the period. Finally, AlphaQuest LLC bought a new stake in shares of The Pennant Group in the 3rd quarter valued at about $137,000. 85.88% of the stock is owned by institutional investors.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.